RKTONasdaqPharmaceutical PreparationsFiscal year ends December 31
Rocket One Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.50−0.01 (-1.97%)
Close on Oct 19, 2026
- Market cap
- $10.21M
- P/E (TTM)
- –
- Dividend yield
- –
Rocket One Inc. revenue by segment
By business segment
| Operating income | Q2 26 | Q4 25 | Q2 25 | YoY |
|---|---|---|---|---|
| AI Infrastructure and Technologies segment [Member] | -$275.96K | – | – | – |
| Biopharmaceutical Segment [Member] | -$3.56M | – | -$2.20M | +61.8% |
By product or service
By region
From the segment and revenue-disaggregation notes of Rocket One's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.